TANDEM DIABETES CARE INC (TNDM) Form 8-K — May 21, 2026
Tandem Diabetes Care (TNDM) held its 2026 Annual Meeting of Stockholders on May 20, 2026, where shareholders approved several key proposals including the election of nine directors and the ratification of Ernst & Young LLP as the independent auditor. Shareholders approved amendments to the Company’s Certificate of Incorporation to allow for the removal of directors with or without cause, aligning with Section 141(k) of the Delaware General Corporation Law, and to limit officer liability to the maximum extent permitted by law.
Key figures
- Shares Present
- 57964375
- Shares Outstanding
- 68504233
- Ltip shares initial
- 2602184
- Ltip shares added 2024
- 3000000
- Ltip shares added 2026
- 3260000
- Total authorized common
- 200000000
- Total authorized preferred
- 5000000
- Ltip shares authorized total
- 8862184
Price after filing
Close on the filing date to close N calendar days later (from $15.76). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.